← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2013Last known activity
Dec 1, 2016
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 3 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT03052413Lead sponsorN/ADec 1, 2016
- NCT02651012Study directorPhase 3Mar 1, 2015
- NCT02651012Lead sponsorPhase 3Mar 1, 2015
- NCT02138539Overall official - principal investigatorPhase 4Oct 1, 2013
- NCT02138539Lead sponsorPhase 4Oct 1, 2013
Details
- Last known activity
- Dec 1, 2016